Value of 18F-FDG PET in the detection of peritoneal carcinomatosis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 10, 2004, Pages 1413-1420

  Suzuki, Akiko ^a   Kawano, Tsuyoshi ^a   Takahashi, Nobukazu ^a   Lee, Jin ^a   Nakagami, Yoshihiro ^a   Miyagi, Etsuko ^a   Hirahara, Fumiki ^a   Togo, Shinji ^a   Shimada, Hiroshi ^a   Inoue, Tomio ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

FDG PET; Peritoneal carcinomatosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOHEXOL; IOPAMIDOL; RADIOPHARMACEUTICAL AGENT; DIAGNOSTIC AGENT;

ABDOMINAL WALL; ADULT; AGED; ARTICLE; ASCITES; BILE DUCT CANCER; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOMETRIUM CANCER; FEMALE; HUMAN; LIVER CANCER; MALE; OVARY CANCER; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; STOMACH CANCER; UTERINE CERVIX CANCER; CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; METHODOLOGY; PERITONEUM TUMOR; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

CARCINOMA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 5444250962     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1577-y     Document Type: Article

References (28)

1. Walkey MM, Friedman AC, Sohotra P, Radecki PD. CT manifestations of peritoneal carcinomatosis. Am J Roentgenol 1988;150:1035-1041
2. Ha HK, Jung JI, Lee MS, Choi BG, Lee MG, Kim YH, Kim PN, Auh YH. CT differentiation of tuberculous peritonitis and peritoneal carcinomatosis. Am J Roentgenol 1996;167:743-748
3. Nelson RC, Chezmar JL, Hoel MJ, Buck DR, Sugarbaker PH. Peritoneal carcinomatosis: preoperative CT with intraperitoneal contrast material. Radiology 1992;182:133-138
4. Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993;72:1631-1636
5. Ricke J, Hosten N. Peritoneal carcinomatosis. Abdom Imaging 1997;22:235-236
6. Chou CK, Liu GC, Chen LT, Jaw TS. MRI manifestations of peritoneal carcinomatosis. Gastrointest Radiol 1992;17:336-338
7. Matsushita M, Hajiro K, Takakuwa H, Nishio A. Transvaginal versus transrectal ultrasonography in the diagnosis of peritoneal carcinomatosis. Am J Gastroenterol 2000;95:1381
8. Rioux M, Michaud C. Sonographic detection of peritoneal carcinomatosis: a prospective study of 37 cases. Abdom Imaging 1995;20:47-51; discussion 56-57
9. Goerg C, Schwerk WB. Malignant ascites: sonographic signs of peritoneal carcinomatosis. Eur J Cancer 1991;27:720-723
10. Stell DA, Carter CR, Stewart I, Anderson JR. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg 1996;83:1260-1262
11. 18F)-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-238
12. Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics 2000;56:345-351
13. Inoue T, Koyama K, Onuchi N, Alyafei S, Yuan Z, Suzuki H, Takeuchi K, Tomaru Y, Tomiyoshi K, Aoki J, Endo K. Detection of malignant tumors: whole-body PET with fluorine 18 α-methyl tyrosine versus FDG-preliminary study. Radiology 2001;220:54-62
14. 18F-FDG PET. J Nucl Med 2003;44:1407-1412
15. Drieskens O, Stroobants S, Gysen M, Vandenbosch G, Mortelmans L, Vergote I. Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer. Gynecol Obstet Invest 2003;55:130-134
16. Turlakow A, Yeung HW, Macapinlac HA, Nunez RF, Sanchez AF, Larson SM. Peritoneal carcinomatosis: the role of FDG-PET. J Nucl Med 2000; Suppl abstr:S36
17. Lin EC, Lear J, Quaife FA. Metastatic peritoneal seeding patterns demonstrated by FDG positron emission tomographic imaging. Clin Nucl Med 2001;26:249-250
18. Lin EC. "Straight line" sign of diffuse peritoneal carcinomatosis on sagittal FDG positron emission tomographic images. Clin Nucl Med 2002;27:735-736
19. Sheth S, Horton KM, Garland MR, Fishman EK. Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis. Radiographics 2003;23:457-473
20. Healy JC, Reznek RH. The peritoneum, mesenteries and omenta: normal anatomy and pathological processes. Eur Radiol 1998;8:886-900
21. Shreve PD, Bui CDH. Normal variants in FDG-PET imaging. In: Wahl RL, ed. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams & Wilkins; 2002:111-136
22. Pannu HK, Bristow RE, Montz FJ, Fishman EK. Multidetector CT of peritoneal carcinomatosis from ovarian cancer. Radiographics 2003;23:687-701
23. Raptopoulos V, Gourtsoyiannis N. Peritoneal carcinomatosis. Eur Radiol 2001;11:2195-2206
24. Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol 2000;27:643-646
25. 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001;42:1412-1417
26. Smith GT, Hubner KF, McDonald T, Thie JA. Cost analysis of FDG PET for managing patients with ovarian cancer. Clin Positron Imaging 1999;2:63-70
27. Arulampalam T, Costa D, Visvikis D, Boulos P, Taylor I, Ell P. The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur J Nucl Med 2001;28:1758-1765
28. Saga T, Torizuka T, Ouchi Y, Nishizawa S, Yonekura Y, Ochi H, Miyama M, Shiomi S, Uno K, Konishi J, Torizuka K Clinical usefulness and cost-effectiveness of FDG-PET in the staging and follow up of patients with gynecological malignancies-an analysis based on multi-center survey. Radioisotopes 2003,52 11